JPMorgan Funds - Thematics - Genetic Therapies I2 (acc) - EUR (hedged)

WKN A2P00D | ISIN LU2127216625 |  Fonds
Factsheet
03.04.25
75,35 EUR-0,57 % (-0,43)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 BE0170813936 KBC Equity Fund Medical Technologies Classic +6,99 % +11,29 % 0,41
2 LU2036818289 CPR Invest - MedTech - H USD - Acc +6,61 % +12,22 % 0,35
3 LU2194372939 Bellevue Funds (Lux) - Bellevue Medtech & Services U2 USD - Accumulating +6,16 % +12,73 % 0,30
4 LU2384387564 CPR Invest - MedTech - A HUF - Acc +6,48 % +14,24 % 0,29
5 LU2194372855 Bellevue Funds (Lux) - Bellevue Medtech & Services U USD - Accumulating +5,86 % +12,73 % 0,28
423 LU2127216625 JPMorgan Funds - Thematics - Genetic Therapies I2 (acc) - EUR (hedged) -20,31 % +21,36 % -1,06
439 LU1864482945 Candriam Equities L Oncology, R - Capitalisation -12,75 % +11,76 % -1,28
440 LU2053353582 JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged) -22,13 % +21,31 % -1,15
441 LU2098775385 JPMorgan Funds - Thematics - Genetic Therapies C (acc) - CHF (hedged) -22,20 % +21,31 % -1,15
442 LU2053353400 JPMorgan Funds - Thematics - Genetic Therapies A (acc) - CHF (hedged) -22,55 % +21,31 % -1,17
443 LU2444844174 Allianz Sustainable Health Evolution - WT6 - GBP -14,07 % +12,81 % -1,28